The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Source link : https://www.nytimes.com/2024/09/20/health/ftc-drug-price-inflation-insulin.html
Author : Reed Abelson and Rebecca Robbins
Publish date : 2024-09-20 19:16:14
Copyright for syndicated content belongs to the linked Source.
